Go to content
UR Home

HCC recurrence in HCV‐infected patients after liver transplantation: SiLVER Study reveals benefits of sirolimus in combination with CNIs – a post‐hoc analysis

URN to cite this document:
urn:nbn:de:bvb:355-epub-445677
DOI to cite this document:
10.5283/epub.44567
Werner, Jens M. ; Hornung, Matthias ; Krah, Rubertha ; Götz, Markus ; Schnitzbauer, Andreas A. ; Schlitt, Hans J. ; Geissler, Edward K. ; the International SiLVER study group, .
[img]
Preview
License: Creative Commons Attribution Non-commercial 4.0
PDF - Published Version
(831kB)
Date of publication of this fulltext: 26 Jan 2021 18:21


Abstract

Factors affecting outcomes in liver transplant (LTx) recipients with hepatocellular carcinoma (HCC) and hepatitis C viral (HCV) infection include the choice of immunosuppression. Here, we analyzed the HCV+ subgroup of patients from the randomized controlled, international SiLVER Study. We performed a post hoc analysis of 166 HCV+ SiLVER Study patients regarding HCC outcome after LTx. Control ...

plus


Owner only: item control page
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons